Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingJun 5, 2024Pain WizardOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0524-2024Class IIOngoingJun 5, 2024ALOE GATOROut of Specification for active ingredientARG Laboratories, Inc. · D-0523-2024Class IIOngoingJun 5, 2024Bull Frog SPF 50 Amphibious Lotion SPF 50 Amphibious Lotion with Water Armor TechOut of Specification for active ingredientARG Laboratories, Inc. · D-0522-2024Class IIOngoingJun 5, 2024NATURAL PAIN RELIEVING CREAMOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0521-2024Class IIOngoingJun 5, 2024Pain WizardOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0520-2024Class IIOngoingJun 5, 2024Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular...Lack of Assurance of SterilityImprimis NJOF, LLC · D-0519-2024Class IITerminatedJun 5, 2024Cefdinir for Oral Suspension USPDefective container: lack of seal integrity.Lupin Pharmaceuticals Inc. · D-0518-2024Class IIOngoingJun 5, 2024Metoprolol Tartrate Tablets USPPresence of Foreign Substance: metal in tabletRubicon Research Private Limited · D-0517-2024Class IIOngoingJun 5, 2024Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of SterilityImprimis NJOF, LLC · D-0516-2024Class IIOngoingJun 5, 2024Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of SterilityImprimis NJOF, LLC · D-0515-2024Class IIOngoingJun 5, 2024Dexamethasone-Moxifloxacin- KetorolacLack of Assurance of SterilityImprimis NJOF, LLC · D-0514-2024Class IIOngoingJun 5, 2024Dexamethasone-MoxifloxacinLack of Assurance of SterilityImprimis NJOF, LLC · D-0513-2024Class IIOngoingJun 5, 2024Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular...Lack of Assurance of SterilityImprimis NJOF, LLC · D-0512-2024Class IOngoingJun 5, 2024Tirzepatide 10 mg/0.5 mL Sterile SolutionLabeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionateRevive Rx LLC dba Revive Rx Pharmacy · D-0511-2024Class IIOngoingJun 5, 2024Zoledronic Acid Injection 5mg/100mL Sterile SolutionLack of Assurance of Sterility: Leaking vialsDr. Reddy's Laboratories, Inc. · D-0510-2024Class IITerminatedJun 5, 2024Cathflo activaseLack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.Genentech, Inc. · D-0509-2024Class ICompletedMay 29, 2024Phenylephrine in 0.9% Sodium Chloride Injection Preservative FreeLabeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.Hikma Injectables USA Inc · D-0508-2024Class IITerminatedMay 29, 2024Vasopressin InjectionSubpotent product in addition to having out-of-specification results for impurities.American Regent, Inc. · D-0507-2024Class IIOngoingMay 29, 2024Haloperidol decanoate Injection 50mg/mLPresence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).Somerset Therapeutics LLC · D-0506-2024Class IIOngoingMay 29, 2024Duloxetine Delayed-Release Cap USP 30mgCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitPreferred Pharmaceuticals, Inc. · D-0505-2024Class IIIOngoingMay 29, 2024Sirolimus Tablets 1mg TabletsFailed Impurities/Degradation SpecificationsDr. Reddy's Laboratories, Inc. · D-0504-2024Class IITerminatedMay 29, 2024niCARdipine Hydrochloride InjectionLack of Assurance of Sterility.American Regent, Inc. · D-0503-2024Class IIIOngoingMay 29, 2024XelprosFailed Release Testing: Out of specification for particulate matter test.Sun Pharmaceutical Industries Inc · D-0502-2024Class IIOngoingMay 22, 2024Meijer Magnesium Citrate Saline Laxative Oral Solution Dye FreeMicrobial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteriaPharma Nobis LLC · D-0501-2024Class IIOngoingMay 22, 2024CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry FlavorMicrobial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteriaPharma Nobis LLC · D-0500-2024Class IIOngoingMay 22, 2024MethylPREDNISolone Acetate Injectable SuspensionPresence of Particulate Matter: Potential for black particulates in the drug product.Sagent Pharmaceuticals · D-0499-2024Class IIOngoingMay 22, 2024Losartan Potassium and Hydrochlorothiazide TabletsPresence of foreign substance: plastic-like substance.Macleods Pharma USA, Inc · D-0498-2024Class IITerminatedMay 22, 2024Cefdinir for Oral Suspension USP 125 mg/5 mLPresence of foreign substance: Product complaint of foreign material in reconstituted bottle.Lupin Pharmaceuticals Inc. · D-0497-2024Class IITerminatedMay 22, 2024Cefdinir for Oral Suspension USP 250 mg/5 mLPresence of foreign substance: Product complaint of foreign material in reconstituted bottle.Lupin Pharmaceuticals Inc. · D-0496-2024Class IICompletedMay 22, 2024Gordofilm Wart RemovercGMP DeviationsDercher Enterprises, Inc., DBA Gordon Laboratories · D-0495-2024Class ITerminatedMay 22, 2024Schwinnng Herbal Dietary Supplement CapsulesMarketed Without An Approved NDA/ANDAStop Clopez Corp · D-0494-2024Class IIOngoingMay 15, 2024Amphotericin B Liposome for InjectionOut of specification for assaySun Pharmaceutical Industries Inc · D-0493-2024Class IIOngoingMay 15, 2024Clorazepate Dipotassium TabletsDiscoloration: Dotted and yellow spots on tabletsAurobindo Pharma USA Inc. · D-0492-2024Class IIOngoingMay 15, 2024Clorazepate Dipotassium TabletsDiscoloration: Dotted and yellow spots on tabletsAurobindo Pharma USA Inc. · D-0491-2024Class IIITerminatedMay 15, 2024Sodium Sulfacetamide 10% - Sulfur 5% CleanserSubpotent drugAcella Pharmaceuticals, LLC · D-0490-2024Class IITerminatedMay 15, 2024TraMADol HCl 50 mg TabletPresence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadolRemedyRepack Inc. · D-0489-2024Class IITerminatedMay 15, 2024Timolol Maleate Ophthalmic SolutionDefective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.FDC Limited · D-0488-2024Class IIOngoingMay 15, 2024traMADol Hydrochloride TabletsPresence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadolRubicon Research Private Limited · D-0487-2024Class IOngoingMay 15, 2024Sapropterin Dihydrochloride Powder for Oral Solution 100mgSub-potent Drug; powder discoloration associated with decreased potencyDr. Reddy's Laboratories, Inc. · D-0486-2024Class IOngoingMay 15, 2024JavygtorSub-potent Drug; powder discoloration associated with decreased potencyDr. Reddy's Laboratories, Inc. · D-0485-2024